May 18 - 22, 2025
Brussels, Belgium
IFCC-EFLM
EuroMedLab 2025
Pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
- We understand the weight of the responsibility you carry and the enormity of the challenges you face to deliver the insights hidden in that blood – quickly, consistently, and accurately – day after day.
- We understand your staff is stretched and under constant pressure to perform at their best.
- We understand the need for more than a one-size fits all approach. Whether it’s in the main lab or at the point of care or anywhere in between, you need creative solutions that are tailored to your unique situation.
Setting a new bar in performance, we are delivering bespoke solutions that go beyond standardization to deliver efficiency and intelligence across your network. Our next level of system innovation is thoughtfully engineered to better suit your distinct needs, while caring for the morale and safety of your team and our planet.
Our expert team walks beside you: our engineers, scientists, physicians, workflow specialists and service personnel are all working day after day to bring you the tailored solutions that make it easier for your staff, your lab, and your institution – because we understand the vital role you play in patients’ lives with every test.
We look forward to seeing you at EUROMEDLAB BRUSSELS 2025. Join us at to meet our team of experts and learn about innovations and trends in clinical diagnostics and point-of-care testing.
Don't miss the latest! Register for exclusive access to expert videos and insights and get personalized recommendations.
We ❤ the lab: Care for the care team
We ❤ the lab
Labs play a critical role in healthcare delivery.
But it’s a tough place to work right now. It’s difficult to attract and retain a skilled workforce, and current staff are experiencing high levels of burnout. Just simplifying operations won’t solve these issues. Care team well-being includes a safe, predictable workplace. One with a reduced burden of stringent regulatory requirements and full of development opportunities. Visit us and learn how to improve the morale and safety of your team – and care for our planet – all while making the lab the hero of the health system.
Strategies for going beyond standardization
Standardization across a health network
The definition of standardization across a health network
is shared reagents, common user interfaces, and reduced training needs. With continued consolidation of healthcare organizations and the ever-changing dynamics of the clinical diagnostics market, today’s laboratories must be agile–going beyond just standardization.
Acute care through the lens of critical assays
Meeting guidelines and turnaround time goals with confidence can be one of the lab’s greatest challenges.
Only 1 in 10 emergency department patients
with chest pain are experiencing an AMI.2 The other nine are taking up an ED bed waiting to be discharged. Clinicians are waiting on actionable test results to effectively treat patients – in the surgical suite, wards, or the ED. Meeting guidelines and TAT goals with confidence can be one of the lab’s greatest challenges.
Meeting the rising tide of chronic diseases
Learn how Siemens Healthineers can help you address the growing prevalence of chronic diseases.
Responsible for 63% of all deaths,
non-communicable diseases will cost the world $30 trillion by 2030.3 Not only did the pandemic delay care for chronic disease patients, but it brought about further democratization of testing. Patients with liver disease, kidney disease, diabetes, and allergies are taking command of their health. Clinicians are looking for tools for risk assessment.
We look forward to seeing you in Brussels in 2025.
Join us at EuroMedLab Brussels 2025, where we will share our newest innovations to help you deliver high value care, and confidently provide the answers your clinicians and patients expect.
The Brussels Exhibition Centre at the Brussels Expo. Photo credit: www.visit.brussels
Congress Overview
EUROMEDLAB Brussels 2025
- 26th IFCC-EFLM EuroMedLab Congress of Clinical Chemistry and Laboratory Medicine
- 49th Annual Meeting of the Royal Belgian Society of Laboratory Medicine
Congress Dates: 18-22 May 2025
Exhibition Dates: 19-22 May 2025
Venue: Brussels Expo Map:
Hosted by
Are you interested?
Share
Do you find this page interesting? Share the information with peers.
Availability of products mentioned herein may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.
Atellica, epoc, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.
1
Atellica Hematology Analyzers not available for sale in the U.S. The products/features mentioned here are not commercially available in all countries. Their future availability cannot be guaranteed. Track-based automation connectivity for the Atellica HEMA Analyzers is under development. Not available for sale. Future availability cannot be guaranteed.
2
https://www.acep.org/imports/clinical-and-practice-management/resources/administration/observation-svcs/chest-pain-units-in-emergency-departments/
3
https://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf
4
In the U.S., the ELF Test is not for use in the diagnosis of NASH or for the staging of fibrosis. The ELF Test is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events.
Sources for 3D VWF visual:
PDB: 1SQ0
Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS, Mosyak L. Crystal structure of the complex of the wild-type von Willebrand factor A1 domain and glycoprotein Ib alpha at 2.6 angstrom resolution. 2004. doi: 10.2210/pdb1SQ0/pdb
Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS, Mosyak L. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem. 2004;279:23327-34. doi: 10.1074/jbc.M401659200